How antibiotics kill bacteria: from targets to networks

Keywords

Biology, Antibiotics, Computational biology, Bacteria, Drug

References

• Lytic effect of two fluoroquinolones, ofloxacin and pefloxacin, on Escherichia coli W7 and its consequences on peptidoglycan composition高元 渡辺 — 1991
• DNA gyrase, topoisomerase IV, and the 4-quinolonesHerbert L. Foster — 1997
• Determination of Antibiotic Hypersensitivity among 4,000 Single-Gene-Knockout Mutants of Escherichia coliJohn L. Shelton, Erica M. Meyer — 2008
• The Ribosome, Structure, Function, Antibiotics, and Cellular InteractionsRoger A. Garrett — 2000
• Antibiotics: Actions, Origins, ResistanceChristopher T. Walsh — 2003
• ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotypeRosario Múñoz, Adela G. de la Campa — 1996
• The importance of repairing stalled replication forksMichael M. Cox, Myron F. Goodman, Kenneth N. Kreuzer — 2000
• Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosomeMarina V. Rodnina, Tillmann Pape, Wolfgang Wintermeyer — 2000
• Multicomponent therapeutics for networked systemsCurtis T. Keith, Alexis A. Borisy, Brent R. Stockwell — 2005
• How oxygen damages microbes: oxygen tolerance and obligate anaerobiosis.James A. Imlay — 2002
• Emergence of vancomycin tolerance in Streptococcus pneumoniaeRobert W. Novak, Birgitta Henriques, Emmanuelle Charpentier — 1999
• Identification of LytSR-regulated genes from Staphylococcus aureusEric W. Brunskill, Kenneth W. Bayles — 1996
• Cell division inhibitors SulA and MinCD prevent formation of the FtsZ ringErfei Bi, Joe Lutkenhaus — 1993
• MECHANISM OF ACTION OF NALIDIXIC ACID ON ESCHERICHIA COLIWilliam A. Goss, William H. Deitz, Thomas M. Cook — 1964
• Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide.Yasuhisa Kono — 1982
• Antibiotic Inhibitors of the Bacterial RibosomeBernard Weisblum, Julian Davies — 1968
• On the mechanism of rifampicin inhibition of RNA synthesis.William R. McClure, Carol L. Cech — 1978
• RecA-dependent recovery of arrested DNA replication forks.Justin Courcelle, Philip C. Hanawalt — 2003
• Two bactericidal targets for penicillin in pneumococci: autolysis-dependent and autolysis-independent killing mechanismsPhilippe Moreillon, Z Markiewicz, Sharon Nachman — 1990
• Structure of the A Site of Escherichia coli 16S Ribosomal RNA Complexed with an Aminoglycoside AntibioticDominique Fourmy, Michael I. Recht, Scott C. Blanchard — 1996

Cited by

• Biosensors, antibiotics and food.Nina Virolainen, Matti Karp — 2014
• Reactive nanostructured membranes for water purificationKelly Gordon, S. Anderson, B Gribble — 2011
• RNA modifications by oxidation: a novel disease mechanism?易开刚 — 2012
• Investigation of antimicrobials from native British plants used in 10th century Anglo-Saxon wound healing formulationsFrances Watkins — 2013
• Structure-Based Gene Targeting Discovery of a Novel Bacterial Translocase I Inhibitor, SphaerimicinMaría Jesús Peñas Moyano — 2013
• Single-cell, real-time detection of oxidative stress induced in Escherichia coli by the antimicrobial peptide CM15Шарафеев Айдар Зайтунович — 2015
• Shaping Nanoparticles with Hydrophilic Compositions and Hydrophobic Properties as Nanocarriers for Antibiotic Delivery寛明 耳塚 — 2015
• Pharmacological evaluation of poly(3-methylthiophene) and its titanium(IV)phosphate nanocomposite: DNA interaction, molecular docking, and cytotoxic activity.Eva María Sanz Peces, José Ciércoles Prado, Ana María Tordable Ramírez — 2016
• Quinolone Resistance Reversion by Targeting the SOS ResponseR.E.H.M. Smits, Mary C. Rogers — 2017
• Glutathione Enhances Antibiotic Efficiency and Effectiveness of DNase I in Disrupting Pseudomonas aeruginosa Biofilms While Also Inhibiting Pyocyanin Activity, Thus Facilitating Restoration of Cell Enzymatic Activity, Confluence and ViabilityScott Weaven, Debra Grace — 2017
• Drugging tRNA aminoacylationFernando Siscar Bolumar — 2018
• Response of ginger growth to a tetracycline-contaminated environment and residues of antibiotic and antibiotic resistance genes.Volkmar Plagentz — 2018
• The antimicrobial action of polyaniline involves production of oxidative stress while functionalisation of polyaniline introduces additional mechanisms卯三郎 佐藤, 英穂 田村, 茂雄 新井 — 2018
• Mechanical Genomic Studies Reveal the Role of d-Alanine Metabolism in Pseudomonas aeruginosa Cell StiffnessJulianna Mv Kele-Olovsson — 2018
• Transcriptional Landscape of a blaKPC-2 Plasmid and Response to Imipenem Exposure in Escherichia coli TOP10Emmah Ntlhapisang Khunwane — 2018
• Enhanced NADH Metabolism Involves Colistin-Induced Killing of Bacillus subtilis and Paenibacillus polymyxa賢長 松浦, 善之 樋口, 由香理 杉村 — 2019
• Anti-infective potential of hydroalcoholic extract of Punica granatum peel against gram-negative bacterial pathogensIgnacio Arroyo Martínez — 2019
• Electrochemical control of bacterial persister cellsTagbo H. R. Niepa — 2014
• Genotypic and phenotypic characterisation of Staphylococcus epidermidis isolated from prosthetic joint infectionsBengt Hellmark — 2011
• Cambios en la fisiología de Pseudomonas aeruginosa causados por la sobre-expresión del sistema múltiple de bombeo MexEF-OprNO. Pacheco, J. Andrés — 2013

Related papers

• Effect of Metazoa on Proportion of Physiologically Active BacteriaNaoshi Fujimoto, Iida Asuka, Masaharu Suzuki — 1999
• The features of use of antibiotics in the hospitalized patients staying in the department of nephrologyHE Ya — 2008
• Analysis on the Use of Antibiotics in Surgical PatientsHu Qin — 2008
• The screening and identification of oil degradation bacteria producing surfactantHua Liu — 2014
• Non-antibiotics reverse resistance of bacteria to antibiotics.Jette E. Kristiansen, Villy Frølund Thomsen, Ana Martins — 2010
• Using model-system genetics for drug-based target discovery.David J. Matthews, Jenny Kopczynski — 2001
• Structural biology and drug discovery.Miles Congreve, Christopher W. Murray, Tom L. Blundell — 2005
• The use of constitutively active GPCRs in drug discovery and functional genomicsDerek Chalmers, Dominic P. Behan — 2002
• The modular approach to ligand discovery.Charles Karan, John A. Tallarico — 2004
• Functional cell-based uHTS in chemical genomic drug discovery.Glenn Croston — 2002